30-Jun-2026 16:38:43
CORONAExpansion
CORONA REMEDIES : EXPANDS MANUFACTURING CAPACITY AT WOMEN'S HORMONE FACILITY
• Company has inaugurated and commenced commercial production at its EU-GMP approved Women's Hormone manufacturing facility at Bhayla, Ahmedabad. • The facility has an annual manufacturing capacity of 194 million tablets/capsules and 1.5 million ointments/gels. • This intimation is also available on the company's website.
Corona Remedies Ltd
Open attachment